메뉴 건너뛰기




Volumn 8, Issue 8, 2007, Pages 502-510

Optimizing Insulin Use in Type 2 Diabetes: Role of Basal and Prandial Insulin in Long-Term Care Facilities

Author keywords

insulin; Long term care; oral antidiabetic drugs; type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; CHLORPROPAMIDE; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; MEGLITINIDE; METFORMIN; MIGLITOL; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PRAMLINTIDE; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; SULFONYLUREA;

EID: 34948829557     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2007.08.002     Document Type: Review
Times cited : (30)

References (94)
  • 1
    • 5044228670 scopus 로고    scopus 로고
    • Analyses of nursing home residents with diabetes at admission
    • Travis S.S., Buchanan R.J., Wang S., et al. Analyses of nursing home residents with diabetes at admission. J Am Med Dir Assoc 5 (2004) 320-327
    • (2004) J Am Med Dir Assoc , vol.5 , pp. 320-327
    • Travis, S.S.1    Buchanan, R.J.2    Wang, S.3
  • 2
    • 28744436260 scopus 로고    scopus 로고
    • Comorbidities among Ohio's nursing home residents with diabetes
    • Duffy R.E., Mattson B.J., and Zack M. Comorbidities among Ohio's nursing home residents with diabetes. J Am Med Dir Assoc 6 (2005) 383-389
    • (2005) J Am Med Dir Assoc , vol.6 , pp. 383-389
    • Duffy, R.E.1    Mattson, B.J.2    Zack, M.3
  • 3
    • 21544460165 scopus 로고    scopus 로고
    • Hospitalizations, nursing home admissions, and deaths attributable to diabetes
    • Russell L.B., Valiyeva E., Roman S.H., et al. Hospitalizations, nursing home admissions, and deaths attributable to diabetes. Diabetes Care 28 (2005) 1611-1617
    • (2005) Diabetes Care , vol.28 , pp. 1611-1617
    • Russell, L.B.1    Valiyeva, E.2    Roman, S.H.3
  • 4
    • 35148870802 scopus 로고    scopus 로고
    • Diabetes and long-term care
    • Harris M.I., Cowie C.C., Stern M.P., et al. (Eds), National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
    • Mayfield J.A., Deb P., and Potter D.E.B. Diabetes and long-term care. In: Harris M.I., Cowie C.C., Stern M.P., et al. (Eds). Diabetes in America. 2nd ed. (2004), National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
    • (2004) Diabetes in America. 2nd ed.
    • Mayfield, J.A.1    Deb, P.2    Potter, D.E.B.3
  • 5
    • 33845996154 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2007
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl 1 (2007) S4-S41
    • (2007) Diabetes Care , vol.30 , Issue.SUPPL. 1
  • 6
    • 35148872651 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. Data & trends. National diabetes surveillance system. Prevalence of diabetes: Prevalence of diagnosed diabetes by age, United States, 1980-2005. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figbyage.htm. Accessed July 23, 2007.
  • 7
    • 2642626655 scopus 로고    scopus 로고
    • Economic consequences of diabetes mellitus in the U.S. in 1997
    • American Diabetes Association
    • American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21 (1998) 296-309
    • (1998) Diabetes Care , vol.21 , pp. 296-309
  • 8
    • 0043244907 scopus 로고    scopus 로고
    • Economic costs of diabetes in the U.S. in 2002
    • American Diabetes Association
    • American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26 (2003) 917-932
    • (2003) Diabetes Care , vol.26 , pp. 917-932
  • 9
    • 80051546846 scopus 로고    scopus 로고
    • Cost of glycemic control in long term care
    • Smith S.A., Cabanala R.L., Anderson S.S., et al. Cost of glycemic control in long term care. Diabetes 54 Suppl 1 (2006) A1-A733
    • (2006) Diabetes , vol.54 , Issue.SUPPL. 1
    • Smith, S.A.1    Cabanala, R.L.2    Anderson, S.S.3
  • 10
    • 33646260470 scopus 로고    scopus 로고
    • Medicare coverage for patients with diabetes. A national plan with individual consequences
    • Ashkenazy R., and Abrahamson M.J. Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med 21 (2006) 386-392
    • (2006) J Gen Intern Med , vol.21 , pp. 386-392
    • Ashkenazy, R.1    Abrahamson, M.J.2
  • 11
    • 0032977099 scopus 로고    scopus 로고
    • Reported and measured physical functioning in older inner-city diabetic African Americans
    • Miller D.K., Lui L.-Y.L., Perry III H.M., et al. Reported and measured physical functioning in older inner-city diabetic African Americans. J Gerontol A Biol Sci Med Sci 54A (1999) M230-M236
    • (1999) J Gerontol A Biol Sci Med Sci , vol.54 A
    • Miller, D.K.1    Lui, L.-Y.L.2    Perry III, H.M.3
  • 12
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Stratton I.M., Adler A.I., Neil H.A.W., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.W.3
  • 13
    • 0037472879 scopus 로고    scopus 로고
    • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    • Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393
    • (2003) N Engl J Med , vol.348 , pp. 383-393
    • Gaede, P.1    Vedel, P.2    Larsen, N.3
  • 14
    • 35148874614 scopus 로고    scopus 로고
    • Optimization of treatment of type 2 diabetes in the elderly
    • Available at: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/SrConsu ltcfm.cfm&pub_id=8&article_id=621. Accessed July 23, 2007.
    • Konzem S.L. Optimization of treatment of type 2 diabetes in the elderly. US Pharmacist 25 (2000). http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/SrConsu ltcfm.cfm&pub_id=8&article_id=621 Available at: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/SrConsu ltcfm.cfm&pub_id=8&article_id=621. Accessed July 23, 2007.
    • (2000) US Pharmacist , vol.25
    • Konzem, S.L.1
  • 15
    • 33947715412 scopus 로고    scopus 로고
    • Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: Outcome of a 6-year prospective study
    • Katakura M., Naka M., Kondo T., et al. Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: Outcome of a 6-year prospective study. Diabetes 54 Suppl 1 (2005) A733
    • (2005) Diabetes , vol.54 , Issue.SUPPL. 1
    • Katakura, M.1    Naka, M.2    Kondo, T.3
  • 16
    • 0030775291 scopus 로고    scopus 로고
    • The cost to health plans of poor glycemic control
    • Gilmer T.P., O'Connor P.J., Manning W.G., et al. The cost to health plans of poor glycemic control. Diabetes Care 20 (1997) 1847-1853
    • (1997) Diabetes Care , vol.20 , pp. 1847-1853
    • Gilmer, T.P.1    O'Connor, P.J.2    Manning, W.G.3
  • 17
    • 11844298970 scopus 로고    scopus 로고
    • Predictors of health care costs in adults with diabetes
    • Gilmer T.P., O'Connor P.J., Rush W.A., et al. Predictors of health care costs in adults with diabetes. Diabetes Care 28 (2005) 59-64
    • (2005) Diabetes Care , vol.28 , pp. 59-64
    • Gilmer, T.P.1    O'Connor, P.J.2    Rush, W.A.3
  • 18
    • 33646384383 scopus 로고    scopus 로고
    • The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus
    • Zarowitz B.J., Tangalos E.G., Hollenack K., et al. The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus. J Am Med Dir Assoc 7 (2006) 234-240
    • (2006) J Am Med Dir Assoc , vol.7 , pp. 234-240
    • Zarowitz, B.J.1    Tangalos, E.G.2    Hollenack, K.3
  • 19
    • 25644444543 scopus 로고    scopus 로고
    • Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility
    • Maurer M.S., Burcham J., and Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 60 (2005) 1157-1162
    • (2005) J Gerontol A Biol Sci Med Sci , vol.60 , pp. 1157-1162
    • Maurer, M.S.1    Burcham, J.2    Cheng, H.3
  • 20
    • 0036062666 scopus 로고    scopus 로고
    • Low muscle mass of the thigh is significantly correlated with delirium and worse functional outcome in older medical patients
    • Weinrebe W., Güneysu S., and Welz-Barth A. Low muscle mass of the thigh is significantly correlated with delirium and worse functional outcome in older medical patients. J Am Geriatr Soc 50 (2002) 1310-1311
    • (2002) J Am Geriatr Soc , vol.50 , pp. 1310-1311
    • Weinrebe, W.1    Güneysu, S.2    Welz-Barth, A.3
  • 21
    • 33749462321 scopus 로고    scopus 로고
    • Is weight loss harmful to older men?
    • Morley J.E. Is weight loss harmful to older men?. Aging Male 9 (2006) 135-137
    • (2006) Aging Male , vol.9 , pp. 135-137
    • Morley, J.E.1
  • 22
    • 17644419677 scopus 로고    scopus 로고
    • Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents
    • Allsworth J.E., Toppa R., Palin N.C., et al. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis 15 (2005) 205-212
    • (2005) Ethn Dis , vol.15 , pp. 205-212
    • Allsworth, J.E.1    Toppa, R.2    Palin, N.C.3
  • 23
    • 35148875565 scopus 로고    scopus 로고
    • Diabetes management in the extended care setting
    • Shubrook J.H., and Gau J.-T. Diabetes management in the extended care setting. Diabetes 54 Suppl 1 (2006) 733
    • (2006) Diabetes , vol.54 , Issue.SUPPL. 1 , pp. 733
    • Shubrook, J.H.1    Gau, J.-T.2
  • 24
    • 2542435289 scopus 로고    scopus 로고
    • Diabetic foot care in a long-term facility
    • Berry R.M., and Hunt Raleigh E.D. Diabetic foot care in a long-term facility. J Gerontol Nurs 30 (2004) 8-13
    • (2004) J Gerontol Nurs , vol.30 , pp. 8-13
    • Berry, R.M.1    Hunt Raleigh, E.D.2
  • 25
    • 0035655133 scopus 로고    scopus 로고
    • The use of a no-concentrated-sweets diet in the management of type 2 diabetes in nursing homes
    • Tariq S.H., Karcic E., Thomas D.R., et al. The use of a no-concentrated-sweets diet in the management of type 2 diabetes in nursing homes. J Am Diet Assoc 101 (2001) 1463-1466
    • (2001) J Am Diet Assoc , vol.101 , pp. 1463-1466
    • Tariq, S.H.1    Karcic, E.2    Thomas, D.R.3
  • 27
    • 35148816545 scopus 로고    scopus 로고
    • US Pharmacopeia, USP Center for the Advancement of Patient Safety July
    • US Pharmacopeia. USP Patient Safety CAPSlink (2003), USP Center for the Advancement of Patient Safety July
    • (2003) USP Patient Safety CAPSlink
  • 28
    • 0031004420 scopus 로고    scopus 로고
    • Diabetes in institutionalised elderly people: A forgotten population?
    • Benbow S.J., Walsh A., and Gill G.V. Diabetes in institutionalised elderly people: A forgotten population?. BMJ 314 (1997) 1868-1869
    • (1997) BMJ , vol.314 , pp. 1868-1869
    • Benbow, S.J.1    Walsh, A.2    Gill, G.V.3
  • 29
    • 0032926966 scopus 로고    scopus 로고
    • Pathophysiology of type 2 diabetes in the elderly
    • Meneilly G.S. Pathophysiology of type 2 diabetes in the elderly. Clin Geriatr Med 15 (1999) 239-253
    • (1999) Clin Geriatr Med , vol.15 , pp. 239-253
    • Meneilly, G.S.1
  • 30
    • 0037968349 scopus 로고    scopus 로고
    • Guidelines for improving the care of the older person with diabetes mellitus
    • California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders With Diabetes
    • California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders With Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 51 Suppl 5 (2003) S265-S280
    • (2003) J Am Geriatr Soc , vol.51 , Issue.SUPPL. 5
  • 31
    • 18644375984 scopus 로고    scopus 로고
    • Mood and cognitive function in elderly diabetic patients living in care facilities
    • Hagemann R., Sartory G., Hader C., et al. Mood and cognitive function in elderly diabetic patients living in care facilities. Dement Geriatr Cogn Disord 19 (2005) 369-375
    • (2005) Dement Geriatr Cogn Disord , vol.19 , pp. 369-375
    • Hagemann, R.1    Sartory, G.2    Hader, C.3
  • 32
    • 17244369031 scopus 로고    scopus 로고
    • Management of diabetes mellitus medications in the nursing home
    • Haas L. Management of diabetes mellitus medications in the nursing home. Drugs Aging 22 (2005) 209-218
    • (2005) Drugs Aging , vol.22 , pp. 209-218
    • Haas, L.1
  • 33
    • 20444437249 scopus 로고    scopus 로고
    • Multi-targeted and aggressive treatment of patients with type 2 diabetes at high risk: What are we waiting for?
    • Gaede P., and Pedersen O. Multi-targeted and aggressive treatment of patients with type 2 diabetes at high risk: What are we waiting for?. Horm Metab Res 37 Suppl 1 (2005) 76-82
    • (2005) Horm Metab Res , vol.37 , Issue.SUPPL. 1 , pp. 76-82
    • Gaede, P.1    Pedersen, O.2
  • 34
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49)
    • Turner R.C., Cull C.A., Frighi V., et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA 281 (1999) 2005-2012
    • (1999) JAMA , vol.281 , pp. 2005-2012
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3
  • 35
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 36
    • 0030842472 scopus 로고    scopus 로고
    • Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited
    • Cleveland Jr. J.C., Meldrum D.R., Cain B.S., et al. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 96 (1997) 29-32
    • (1997) Circulation , vol.96 , pp. 29-32
    • Cleveland Jr., J.C.1    Meldrum, D.R.2    Cain, B.S.3
  • 37
    • 0033377296 scopus 로고    scopus 로고
    • The use of sulphonylureas in the elderly
    • Graal M.B., and Wolffenbuttel B.H.R. The use of sulphonylureas in the elderly. Drugs Aging 15 (1999) 471-481
    • (1999) Drugs Aging , vol.15 , pp. 471-481
    • Graal, M.B.1    Wolffenbuttel, B.H.R.2
  • 38
    • 31544473434 scopus 로고    scopus 로고
    • Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group
    • Sakharova O.V., and Inzucchi S.E. Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group. Postgrad Med 118 (2005) 19-29
    • (2005) Postgrad Med , vol.118 , pp. 19-29
    • Sakharova, O.V.1    Inzucchi, S.E.2
  • 39
    • 0034002527 scopus 로고    scopus 로고
    • Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease
    • Krepinsky J., Ingram A.J., and Clase C.M. Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease. Am J Kidney Dis 35 (2000) 500-505
    • (2000) Am J Kidney Dis , vol.35 , pp. 500-505
    • Krepinsky, J.1    Ingram, A.J.2    Clase, C.M.3
  • 40
    • 0031614038 scopus 로고    scopus 로고
    • Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
    • Lee A., and Morley J.E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 6 (1998) 47-53
    • (1998) Obes Res , vol.6 , pp. 47-53
    • Lee, A.1    Morley, J.E.2
  • 41
    • 10744221639 scopus 로고    scopus 로고
    • Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association
    • Nesto R.W., Bell D., Bonow R.O., et al. Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 27 (2004) 256-263
    • (2004) Diabetes Care , vol.27 , pp. 256-263
    • Nesto, R.W.1    Bell, D.2    Bonow, R.O.3
  • 42
    • 0036708117 scopus 로고    scopus 로고
    • The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics
    • Lee A., Patrick P., Wishart J., et al. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab 4 (2002) 329-335
    • (2002) Diabetes Obes Metab , vol.4 , pp. 329-335
    • Lee, A.1    Patrick, P.2    Wishart, J.3
  • 43
    • 0036183110 scopus 로고    scopus 로고
    • The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents
    • Rosak C. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents. J Diabetes Complications 16 (2002) 123-132
    • (2002) J Diabetes Complications , vol.16 , pp. 123-132
    • Rosak, C.1
  • 44
    • 33646806766 scopus 로고    scopus 로고
    • Toxicology of oral antidiabetic medications
    • Spiller H.A., and Sawyer T.S. Toxicology of oral antidiabetic medications. Am J Health Syst Pharm 63 (2006) 929-938
    • (2006) Am J Health Syst Pharm , vol.63 , pp. 929-938
    • Spiller, H.A.1    Sawyer, T.S.2
  • 45
    • 35148854086 scopus 로고    scopus 로고
    • [prescribing information], Merck & Co., Inc, Whitehouse Station, NJ
    • Januvia. [prescribing information] (2006), Merck & Co., Inc, Whitehouse Station, NJ
    • (2006) Januvia
  • 46
    • 0029839173 scopus 로고    scopus 로고
    • Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at β-cells
    • Kramer W., Müller G., and Geisen K. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at β-cells. Horm Metab Res 28 (1996) 464-468
    • (1996) Horm Metab Res , vol.28 , pp. 464-468
    • Kramer, W.1    Müller, G.2    Geisen, K.3
  • 47
    • 9444284451 scopus 로고    scopus 로고
    • The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium
    • Quast U., Stephan D., Bieger S., et al. The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 53 Suppl 3 (2004) S156-S164
    • (2004) Diabetes , vol.53 , Issue.SUPPL. 3
    • Quast, U.1    Stephan, D.2    Bieger, S.3
  • 48
    • 0035954260 scopus 로고    scopus 로고
    • Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide
    • Mocanu M.M., Maddock H.L., Baxter G.F., et al. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation 103 (2001) 3111-3116
    • (2001) Circulation , vol.103 , pp. 3111-3116
    • Mocanu, M.M.1    Maddock, H.L.2    Baxter, G.F.3
  • 49
    • 0031972156 scopus 로고    scopus 로고
    • UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group
    • Matthews D.R., Cull C.A., Stratton I.M., et al. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 15 (1998) 297-303
    • (1998) Diabet Med , vol.15 , pp. 297-303
    • Matthews, D.R.1    Cull, C.A.2    Stratton, I.M.3
  • 50
    • 18144377715 scopus 로고    scopus 로고
    • Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes
    • Cook M.N., Girman C.J., Stein P.P., et al. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care 28 (2005) 995-1000
    • (2005) Diabetes Care , vol.28 , pp. 995-1000
    • Cook, M.N.1    Girman, C.J.2    Stein, P.P.3
  • 51
    • 0035339878 scopus 로고    scopus 로고
    • The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: A multicenter, randomized, double-blind, placebo-controlled trial
    • Yale J.F., Valiquett T.R., Ghazzi M.N., et al. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: A multicenter, randomized, double-blind, placebo-controlled trial. Ann Intern Med 134 (2001) 737-745
    • (2001) Ann Intern Med , vol.134 , pp. 737-745
    • Yale, J.F.1    Valiquett, T.R.2    Ghazzi, M.N.3
  • 52
    • 1242328748 scopus 로고    scopus 로고
    • Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: A randomized, double-blind trial
    • Dailey G.E., Noor M.A., Park J.-S., et al. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: A randomized, double-blind trial. Am J Med 116 (2004) 223-229
    • (2004) Am J Med , vol.116 , pp. 223-229
    • Dailey, G.E.1    Noor, M.A.2    Park, J.-S.3
  • 53
    • 33745000699 scopus 로고    scopus 로고
    • Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
    • Rosenstock J., Sugimoto D., Strange P., et al. Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care 29 (2006) 554-559
    • (2006) Diabetes Care , vol.29 , pp. 554-559
    • Rosenstock, J.1    Sugimoto, D.2    Strange, P.3
  • 54
    • 18244395527 scopus 로고    scopus 로고
    • A timely transition to insulin: Identifying type 2 diabetes patients failing oral therapy
    • Dailey G. A timely transition to insulin: Identifying type 2 diabetes patients failing oral therapy. Formulary 40 (2005) 114-130
    • (2005) Formulary , vol.40 , pp. 114-130
    • Dailey, G.1
  • 55
    • 3242715178 scopus 로고    scopus 로고
    • New strategies for basal insulin treatment in type 2 diabetes mellitus
    • Dailey G. New strategies for basal insulin treatment in type 2 diabetes mellitus. Clin Ther 26 (2004) 889-901
    • (2004) Clin Ther , vol.26 , pp. 889-901
    • Dailey, G.1
  • 56
    • 0036736185 scopus 로고    scopus 로고
    • When oral agents fail: Practical barriers to starting insulin
    • Korytkowski M. When oral agents fail: Practical barriers to starting insulin. Int J Obes Relat Metab Disord 26 Suppl 3 (2002) S18-S24
    • (2002) Int J Obes Relat Metab Disord , vol.26 , Issue.SUPPL. 3
    • Korytkowski, M.1
  • 58
    • 0031018185 scopus 로고    scopus 로고
    • NIDDM patients' fears and hopes about insulin therapy: The basis of patient reluctance
    • Hunt L.M., Valenzuela M.A., and Pugh J.A. NIDDM patients' fears and hopes about insulin therapy: The basis of patient reluctance. Diabetes Care 20 (1997) 292-298
    • (1997) Diabetes Care , vol.20 , pp. 292-298
    • Hunt, L.M.1    Valenzuela, M.A.2    Pugh, J.A.3
  • 59
    • 32144454714 scopus 로고    scopus 로고
    • Dispelling myths and removing barriers about insulin in type 2 diabetes
    • Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ 32 (2006) 9S-18S
    • (2006) Diabetes Educ , vol.32
    • Meece, J.1
  • 60
    • 0030852089 scopus 로고    scopus 로고
    • Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
    • Shorr R.I., Ray W.A., Daugherty J.R., et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157 (1997) 1681-1686
    • (1997) Arch Intern Med , vol.157 , pp. 1681-1686
    • Shorr, R.I.1    Ray, W.A.2    Daugherty, J.R.3
  • 61
    • 0033535088 scopus 로고    scopus 로고
    • Drug-induced hypoglycemic coma in 102 diabetic patients
    • Ben-Ami H., Nagachandran P., Mendelson A., et al. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 159 (1999) 281-284
    • (1999) Arch Intern Med , vol.159 , pp. 281-284
    • Ben-Ami, H.1    Nagachandran, P.2    Mendelson, A.3
  • 62
    • 24944502062 scopus 로고    scopus 로고
    • Lower risk of hypoglycemia with insulin detemir vs NPH insulin in elderly people with type 2 diabetes: A pooled analysis of phase 3 trials
    • Garber A.J., Kim H., and Santiago O.M. Lower risk of hypoglycemia with insulin detemir vs NPH insulin in elderly people with type 2 diabetes: A pooled analysis of phase 3 trials. Diabetes 54 Suppl 1 (2005) A118
    • (2005) Diabetes , vol.54 , Issue.SUPPL. 1
    • Garber, A.J.1    Kim, H.2    Santiago, O.M.3
  • 63
    • 21544436847 scopus 로고    scopus 로고
    • A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    • Herman W.H., Ilag L.L., Johnson S.L., et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28 (2005) 1568-1573
    • (2005) Diabetes Care , vol.28 , pp. 1568-1573
    • Herman, W.H.1    Ilag, L.L.2    Johnson, S.L.3
  • 64
    • 5044235848 scopus 로고    scopus 로고
    • Diabetes management in long-term care
    • Pandya N. Diabetes management in long-term care. Caring for the Ages 4 (2003) 21-24
    • (2003) Caring for the Ages , vol.4 , pp. 21-24
    • Pandya, N.1
  • 65
    • 35148880063 scopus 로고    scopus 로고
    • Reduced awareness of hypoglycaemia in elderly patients with type 2 diabetes
    • Schultes B., Baron M., Bremer J.P., et al. Reduced awareness of hypoglycaemia in elderly patients with type 2 diabetes. Diabetes 54 Suppl 1 (2005) A1-A733
    • (2005) Diabetes , vol.54 , Issue.SUPPL. 1
    • Schultes, B.1    Baron, M.2    Bremer, J.P.3
  • 66
    • 0033661254 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
    • Lepore M., Pampanelli S., Fanelli C., et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49 (2000) 2142-2148
    • (2000) Diabetes , vol.49 , pp. 2142-2148
    • Lepore, M.1    Pampanelli, S.2    Fanelli, C.3
  • 67
    • 35148877702 scopus 로고    scopus 로고
    • Levemir [package insert]. Princeton, NJ: Novo Nordisk Inc, 2005.
  • 68
    • 35148872188 scopus 로고    scopus 로고
    • Lantus [package insert]. Kansas City: sanofi-aventis U.S. L.L.C., 2006.
  • 69
    • 14744306696 scopus 로고    scopus 로고
    • Insulin treatment in type 2 diabetes
    • Goldstein B.J., and Müller-Wieland D. (Eds), Martin Dunitz Ltd, a member of the Taylor & Francis Group, London
    • Rosenstock J., and Wyne K. Insulin treatment in type 2 diabetes. In: Goldstein B.J., and Müller-Wieland D. (Eds). Textbook of Type 2 Diabetes (2003), Martin Dunitz Ltd, a member of the Taylor & Francis Group, London 131-154
    • (2003) Textbook of Type 2 Diabetes , pp. 131-154
    • Rosenstock, J.1    Wyne, K.2
  • 70
    • 35148875564 scopus 로고    scopus 로고
    • Apidra [package insert]. Kansas City: Aventis Pharmaceuticals Inc., 2005.
  • 71
    • 35148871254 scopus 로고    scopus 로고
    • Humalog [package insert]. Indianapolis: Eli Lilly and Company, 2004.
  • 72
    • 35148876033 scopus 로고    scopus 로고
    • Novolin R [package insert]. Princeton, NJ: Novo Nordisk Inc., 2005.
  • 73
    • 35148901030 scopus 로고    scopus 로고
    • NovoLog [package insert]. Princeton, NJ: Novo Nordisk Inc., 2005.
  • 74
    • 20944432717 scopus 로고    scopus 로고
    • A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir
    • Plank J., Bodenlenz M., Sinner F., et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 28 (2005) 1107-1112
    • (2005) Diabetes Care , vol.28 , pp. 1107-1112
    • Plank, J.1    Bodenlenz, M.2    Sinner, F.3
  • 75
    • 33646254423 scopus 로고    scopus 로고
    • Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: An assessment of treatment flexibility
    • Standl E., Maxeiner S., and Raptis S. Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: An assessment of treatment flexibility. Horm Metab Res 38 (2006) 172-177
    • (2006) Horm Metab Res , vol.38 , pp. 172-177
    • Standl, E.1    Maxeiner, S.2    Raptis, S.3
  • 76
    • 0038587474 scopus 로고    scopus 로고
    • A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes
    • Hamann A., Matthaei S., Rosak C., et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 26 (2003) 1738-1744
    • (2003) Diabetes Care , vol.26 , pp. 1738-1744
    • Hamann, A.1    Matthaei, S.2    Rosak, C.3
  • 77
    • 0242269000 scopus 로고    scopus 로고
    • The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • Riddle M.C., Rosenstock J., Gerich J., et al. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26 (2003) 3080-3086
    • (2003) Diabetes Care , vol.26 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 78
    • 34547667494 scopus 로고    scopus 로고
    • Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C Study
    • Halter J.B., Kennedy L., Herman W.H., et al. Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C Study. Diabetes 55 Suppl 1 (2006) A1-A733
    • (2006) Diabetes , vol.55 , Issue.SUPPL. 1
    • Halter, J.B.1    Kennedy, L.2    Herman, W.H.3
  • 79
    • 33644873468 scopus 로고    scopus 로고
    • Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1C on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial
    • Kennedy L., Herman W.H., Strange P., et al. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1C on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 29 (2006) 1-8
    • (2006) Diabetes Care , vol.29 , pp. 1-8
    • Kennedy, L.1    Herman, W.H.2    Strange, P.3
  • 80
    • 8344235966 scopus 로고    scopus 로고
    • The use of bolus insulin and advancing insulin therapy in type 2 diabetes
    • Karl D.M. The use of bolus insulin and advancing insulin therapy in type 2 diabetes. Curr Diab Rep 4 (2004) 352-357
    • (2004) Curr Diab Rep , vol.4 , pp. 352-357
    • Karl, D.M.1
  • 81
    • 84890634681 scopus 로고    scopus 로고
    • Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in elderly patients with type 2 diabetes
    • Janka H.U., Plewe G., Busch K., et al. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in elderly patients with type 2 diabetes. Diabetes 54 Suppl 1 (2005) A1-A733
    • (2005) Diabetes , vol.54 , Issue.SUPPL. 1
    • Janka, H.U.1    Plewe, G.2    Busch, K.3
  • 83
    • 34147165663 scopus 로고    scopus 로고
    • Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004
    • Rathmann W., Haastert B., Icks A., et al. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care 30 (2007) 848-853
    • (2007) Diabetes Care , vol.30 , pp. 848-853
    • Rathmann, W.1    Haastert, B.2    Icks, A.3
  • 84
    • 34247398253 scopus 로고    scopus 로고
    • An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
    • Palmer A.J., Valentine W.J., Ray J.A., et al. An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK. Curr Med Res Opin 23 (2007) 895-901
    • (2007) Curr Med Res Opin , vol.23 , pp. 895-901
    • Palmer, A.J.1    Valentine, W.J.2    Ray, J.A.3
  • 85
    • 34247366328 scopus 로고    scopus 로고
    • Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland
    • Brändle M., Azoulay M., and Greiner R.-A. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland. Int J Clin Pharmacol Ther 45 (2007) 203-220
    • (2007) Int J Clin Pharmacol Ther , vol.45 , pp. 203-220
    • Brändle, M.1    Azoulay, M.2    Greiner, R.-A.3
  • 86
    • 25844435656 scopus 로고    scopus 로고
    • Incremental cost savings 6 months following initiation of insulin glargine in a Medicaid fee-for-service sample
    • Zhang Q., and Menditto L. Incremental cost savings 6 months following initiation of insulin glargine in a Medicaid fee-for-service sample. Am J Ther 12 (2005) 337-343
    • (2005) Am J Ther , vol.12 , pp. 337-343
    • Zhang, Q.1    Menditto, L.2
  • 87
    • 0642378204 scopus 로고    scopus 로고
    • Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus
    • Rosenblum M.S., and Kane M.P. Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus. J Manag Care Pharm 9 (2003) 309-316
    • (2003) J Manag Care Pharm , vol.9 , pp. 309-316
    • Rosenblum, M.S.1    Kane, M.P.2
  • 88
    • 16344393325 scopus 로고    scopus 로고
    • Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products
    • Bullano M.F., Al-Zakwani I.S., Fisher M.D., et al. Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products. Curr Med Res Opin 21 (2005) 291-298
    • (2005) Curr Med Res Opin , vol.21 , pp. 291-298
    • Bullano, M.F.1    Al-Zakwani, I.S.2    Fisher, M.D.3
  • 89
    • 35148835644 scopus 로고    scopus 로고
    • Byetta [package insert]. San Diego: Amylin Pharmaceuticals, Inc., 2005.
  • 90
    • 16244409838 scopus 로고    scopus 로고
    • Exenatide: A novel incretin mimetic hormone for the treatment of type 2 diabetes
    • Gryskiewicz K.A., and Coleman C.I. Exenatide: A novel incretin mimetic hormone for the treatment of type 2 diabetes. Formulary 40 (2005) 86-90
    • (2005) Formulary , vol.40 , pp. 86-90
    • Gryskiewicz, K.A.1    Coleman, C.I.2
  • 91
    • 35148814885 scopus 로고    scopus 로고
    • Symlin injection [package insert]. San Diego: Amylin Pharmaceuticals, Inc., 2005.
  • 92
    • 35148868637 scopus 로고    scopus 로고
    • Efficacy and safety of pramlintide in insulin-using elderly patients with type 2 diabetes
    • Frias J., Lush C., Kesty N., et al. Efficacy and safety of pramlintide in insulin-using elderly patients with type 2 diabetes. Diabetes 55 Suppl 1 (2006) A1-A733
    • (2006) Diabetes , vol.55 , Issue.SUPPL. 1
    • Frias, J.1    Lush, C.2    Kesty, N.3
  • 93
    • 0042023799 scopus 로고    scopus 로고
    • The direct medical cost of type 2 diabetes
    • Brandle M., Zhou H., Smith B.R.K., et al. The direct medical cost of type 2 diabetes. Diabetes Care 26 (2003) 2300-2304
    • (2003) Diabetes Care , vol.26 , pp. 2300-2304
    • Brandle, M.1    Zhou, H.2    Smith, B.R.K.3
  • 94
    • 0035411216 scopus 로고    scopus 로고
    • A quality improvement project for better glycemic control in hospitalized patients with diabetes
    • Gilman J.A. A quality improvement project for better glycemic control in hospitalized patients with diabetes. Diabetes Educ 27 (2001) 541-546
    • (2001) Diabetes Educ , vol.27 , pp. 541-546
    • Gilman, J.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.